Instrumento Inactivo

Otros idiomas Orgenesis Inc Other OTC

Acciones

US68619K1051

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Orgenesis Inc. agreed to acquire remaining 50% stake in Theracell Laboratories SA. from Theracell Advanced Biotechnology Ltd for $13 million.	12/07
Orgenesis Inc. Announces Directorate Changes	27/06
Orgenesis Provides Business Update for the First Quarter of 2024	21/05
Tranche Update on Orgenesis Inc.'s Equity Buyback Plan announced on May 15, 2020.	20/05
Orgenesis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	20/05
North American Morning Briefing : Powell Comments, -2-	16/04
Orgenesis Provides Year End Business Update	15/04
Tranche Update on Orgenesis Inc.'s Equity Buyback Plan announced on May 15, 2020.	15/04
Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/04
Orgenesis : Non-Reliance on Previously Issued Financial Report - Form 8-K	15/04
Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility	10/04
Germfree and Orgenesis Inc. Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility	10/04
North American Morning Briefing : Stocks Seen -2-	02/04
North American Morning Briefing : Markets Steady -2-	26/03
North American Morning Briefing : Stock Futures -2-	19/03
Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference	18/03
Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes	13/03
Orgenesis Inc. announced that it has received $2.340901 million in funding	05/03
Orgenesis Inc. Announces $2.3 Million Private Placement	04/03
Orgenesis Inc. announced that it expects to receive $2.340901 million in funding	03/03

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Orgenesis Inc Other OTC

Acciones

US68619K1051

Otros idiomas

Filtros